Date: 16 Apr 2011
Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
This study evaluated the question whether length of in utero exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants might affect neonatal outcome and psychomotor development in infancy.
Birth outcome was determined in the offspring of 55 women with major depressive disorder who used SSRI medication for different durations during their pregnancies. At an average age of 14 months, children underwent a pediatric examination and an evaluation with the Bayley Scales of Infant Development (BSID-II).
Duration of in utero exposure to SSRIs was negatively associated with total Apgar scores, specifically the activity subscale. Odds ratios for a low score (<2) on this scale were 3.8 and 6.0 at 1 and 5 min, respectively. Newborns with longer exposure were more often admitted to the Neonatal Intensive Care Unit (p < .03). Mental Development Index scores of the infants were not associated with the length of gestational exposure to SSRIs. A longer duration of exposure increased the risk for lower Psychomotor Developmental Index and Behavioral Rating Scale scores in infancy (p = 0.012 and p = 0.007, respectively) on the BSID-II.
The findings provide evidence that the length of prenatal SSRI antidepressant use can affect neonatal adjustment and can have an effect on psychomotor test scores in infancy. Importantly, the children’s mental development and motor function by neurological examination were within the normal range. Timing of exposure to SSRIs during susceptible periods of fetal development and variations in the severity of maternal depression may have contributed to the associations.
The study received support from the Edwards and Matcovich Family Trust Fund. The authors have no financial relationship with the Edwards and Matcovich Family Trust Fund. The Edwards and Matcovich Family Trust Fund had no input in any aspect or part of the study.
Bayley N (1993) Bayley scales of infant development, 2nd edn. The Psychological Corporation, San Antonio
Beck A (1972) Depression: causes and treatment. University of Pennsylvania Press, Philadelphia
Beck A, Ward C, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMed
Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Di Gianantonio E, Clementi M, Weber-Schoendorfer C, Schaefer C, Ornoy A (2008) Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol 66:695–705PubMed
DSM I (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, D.C
First M, Spitzer RL, Gibbon M, Williams JBW (1997) Structured clinical interview for DSM IV axis I disorders. APA, Washington, D.C
Jacobs B, Azmitia E (1992) Structure and function of the brain serotonin system. Physiol Rev 72:165–215PubMed
Jacobs B, Fornal C (1995) Serotonin and behavior, a general hypothesis. In: Bloom F, Kupfer D (eds) Psychopharmacology, the fourth generation of progress. Raven, New York, pp 461–469
Mattson SN, Calarco K, Kao KK, Jones KL, Chambers CD (2004) Neurodevelopmental outcome of infants and toddlers exposed prenatally to selective serotonin reuptake inhibitors. Clinical and Molecular Teratology 70:261
Pastuszak A, Schick-Boschetto B, Zuber C (1993) Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). J Am Med Assoc 269:2246–2248CrossRef
Radloff L (1977) The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef
Thompson B, Wasserman J, Matula K (1996) The factor structure of the behavior rating scale of the Bayley scales of infant development—II: cross-sample, cross-sectional, and cross-method investigations of construct validity. Educ Psychol Meas 56:460–474CrossRef
- Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development
Volume 217, Issue 2 , pp 211-219
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- SSRI antidepressants
- Duration of fetal exposure
- Apgar scores
- Mental and psychomotor development
- Industry Sectors
- Author Affiliations
- 1. Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Room 2365, Stanford, CA, 94305-5723, USA
- 2. Division of Neonatology and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA
- 3. Division of Medical Genetics, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA
- 4. Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA